Avalo Therapeutics, Inc. (AVTX) Earnings
NASDAQ·Healthcare·Biotechnology
$6.75
-0.22%
Mkt Cap $362.00M
EPS — Estimate vs Actual
Mkt Cap
$362.00M
P/E
—
Fwd P/E
—
P/S
10535.10
Rev TTM
—
EPS TTM
-$5.83
NASDAQ·Healthcare·Biotechnology
$6.75
-0.22%
Mkt Cap $362.00M
Mkt Cap
$362.00M
P/E
—
Fwd P/E
—
P/S
10535.10
Rev TTM
—
EPS TTM
-$5.83